[Hepatitis B and C viruses in hepatocellular carcinoma in Senegal].
作者信息
Ka M M, Ndiaye M F, Herve P, Legueno B, Diop B M, Dangou J M, Niang A, Woto-Gaye G, Mendes V, Diop T M, Ndiaye P D, Bao O
机构信息
Service de Médecine Interne I, CHU A. Le Dantec, Dakar.
出版信息
Dakar Med. 1996;Spec No:59-62.
PMID:14520992
Abstract
摘要
相似文献
1
[Hepatitis B and C viruses in hepatocellular carcinoma in Senegal].
Dakar Med. 1996;Spec No:59-62.
2
[Etiology of hepatocellular carcinomas in Madagascar: results of a study in Antananarivo from October 1995 to October 1996].
Arch Inst Pasteur Madagascar. 1996;63(1-2):62-6.
3
[Comparison of hepatitis B virus and hepatitis C virus seroprevalence in hepatocellular carcinoma].
Dakar Med. 1996;Spec No:21-3.
4
The clinical and pathological features of hepatocellular carcinoma in Nnewi, Nigeria.
Niger J Med. 2011 Jul-Sep;20(3):366-71.
5
[HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study].
Gastroenterol Clin Biol. 2002 Feb;26(2):131-5.
6
High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
J Med Virol. 2005 Dec;77(4):491-9. doi: 10.1002/jmv.20482.
7
Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
J Natl Cancer Inst. 2009 Jul 15;101(14):1019-27. doi: 10.1093/jnci/djp146. Epub 2009 Jun 17.
8
Prevalence of hepatitis C virus among patients with liver disease in the Republic of Yemen.
East Mediterr Health J. 2001 Jul-Sep;7(4-5):771-8.
9
Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection.
J Gastroenterol Hepatol. 2004 Jun;19(6):665-9. doi: 10.1111/j.1440-1746.2003.03334.x.
10
Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
J Gastroenterol Hepatol. 2008 Mar;23(3):459-66. doi: 10.1111/j.1440-1746.2007.05138.x. Epub 2007 Sep 14.
Zotero 插件